pyrrolidonecarboxylic acid has been researched along with Colonic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Varona, A; Caramés, M; García-Alonso, I; Palomares, T | 2 |
| Kapuvári, B; Manea, M; Mezo, G; Schulcz, A; Tejeda, M; Tóvári, J; Vincze, B | 1 |
| Lachowicz, A; Pawlikowski, M; Stepień, H; Szadowska, A; Winczyk, K; Zerek-Mełeń, G | 1 |
| Paulsen, JE | 1 |
| Khoury, MD; Pereira, MA | 1 |
| Reichelt, KL; Skraastad, O | 1 |
7 other study(ies) available for pyrrolidonecarboxylic acid and Colonic Neoplasms
| Article | Year |
|---|---|
Glutathione modulation reverses the growth-promoting effect of growth factors, improving the 5-fluorouracil antitumour response in WiDr colon cancer cells.
Topics: Buthionine Sulfoximine; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Epidermal Growth Factor; Fluorouracil; Glutathione; Hepatocyte Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Pyrrolidonecarboxylic Acid; Thiazolidines; Vascular Endothelial Growth Factor A | 2009 |
Glutathione modulators reverse the pro-tumour effect of growth factors enhancing WiDr cell response to chemotherapeutic agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Camptothecin; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Epidermal Growth Factor; Fluorouracil; Glutathione; Hepatocyte Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Pyrrolidonecarboxylic Acid; Thiazolidines; Vascular Endothelial Growth Factor A | 2010 |
In-vivo antitumour effect of daunorubicin-GnRH-III derivative conjugates on colon carcinoma-bearing mice.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, SCID; Pyrrolidonecarboxylic Acid; Xenograft Model Antitumor Assays | 2012 |
Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
Topics: Adenocarcinoma; Adenoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dimethylhydrazines; Growth Inhibitors; Hyperplasia; Intestinal Mucosa; Male; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1993 |
The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice.
Topics: Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors; Tumor Cells, Cultured | 1993 |
Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon.
Topics: Acetylcysteine; Allyl Compounds; Animals; Anticarcinogenic Agents; Azoxymethane; Colon; Colonic Neoplasms; Dehydroepiandrosterone; Eflornithine; Ellagic Acid; Isothiocyanates; Male; Precancerous Conditions; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Sulfides; Thiazoles; Thiazolidines; Thiocyanates | 1991 |
An endogenous colon mitosis inhibitor reduces proliferation of colon carcinoma cells (HT 29) in serum-restricted medium.
Topics: Cell Division; Colon; Colonic Neoplasms; Culture Media; Humans; Mitosis; Oligopeptides; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1989 |